The Scientist

» industry

Most Recent

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: AbbVie Buys Shire for $54 Billion

AbbVie Buys Shire for $54 Billion

By | July 21, 2014

The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

0 Comments

image: 2014 Salary Survey Closed

2014 Salary Survey Closed

By | July 14, 2014

Check back for the results in November!

3 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Stem Cells Off the Line

Stem Cells Off the Line

By | April 1, 2014

Researchers work to improve the efficiency of cell therapy manufacturing, while developing procedures to ensure consistent quality.      

0 Comments

image: Incubator Boom

Incubator Boom

By | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

2 Comments

image: Antibody Maker Headed to Court

Antibody Maker Headed to Court

By | February 17, 2014

The USDA claims that Santa Cruz Biotechnology, one of the biggest suppliers of antibodies for laboratory research, repeatedly violated the Animal Welfare Act.

6 Comments

image: Biotech, Meet Crowdfunding

Biotech, Meet Crowdfunding

By | February 13, 2014

Proposed regulations from the US Securities and Exchange Commission have the biotech industry tuning in to the roar of the crowd.  

0 Comments

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

image: New Year’s Biotech IPO Boom?

New Year’s Biotech IPO Boom?

By | February 3, 2014

January was a profitable month for biotech companies going public, Burrill & Company says.

5 Comments

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  3. Next Generation: Mobile Microscope Detects DNA Sequences
  4. Tenure Under Attack in Two More States
    The Nutshell Tenure Under Attack in Two More States

    Proposed legislation would eliminate academic tenure at public universities in Iowa and Missouri, echoing a move that has already gutted such permanent posts in Wisconsin.

RayBiotech